Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balances at beginning (in shares) at Dec. 31, 2021   23,665,991    
Balances at beginning at Dec. 31, 2021 $ 48,787 $ 237 $ 182,482 $ (133,932)
Issuances of common stock:        
Share-based compensation (in shares)   476,720    
Share-based compensation 4,126 $ 5 4,121  
Warrant and option exercises (cash and cashless) (in shares)   403,980    
Warrant and option exercises (cash and cashless) 268 $ 4 264  
Issuance of common stock under employee stock purchase plan (in shares)   56,561    
Issuance of common stock under employee stock purchase plan 477   477  
Payments for taxes related to net share settlement of equity awards (in shares)   (24,269)    
Payments for taxes related to net share settlement of equity awards (336)   (336)  
Net loss for the year $ (16,435)     (16,435)
Balance at ending (in shares) at Dec. 31, 2022 24,578,983 24,578,983    
Balances at ending at Dec. 31, 2022 $ 36,887 $ 246 187,008 (150,367)
Issuances of common stock:        
Share-based compensation (in shares)   9,538    
Share-based compensation 6,079   6,079  
Warrant and option exercises (cash and cashless) (in shares)   14,312    
Issuance of common stock under employee stock purchase plan (in shares)   84,430    
Issuance of common stock under employee stock purchase plan 506 $ 1 505  
Payments for taxes related to net share settlement of equity awards (in shares)   (34,534)    
Payments for taxes related to net share settlement of equity awards (210)   (210)  
Net loss for the year $ (22,089)     (22,089)
Balance at ending (in shares) at Dec. 31, 2023 24,652,729 24,652,729    
Balances at ending at Dec. 31, 2023 $ 21,173 $ 247 $ 193,382 $ (172,456)